Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 511807Generated: October 25, 2026

Hydrochloric Acid → Kinase inhibitor-1

https://huagongshe.com/reaction/511807

Reaction equation

Participants

RoleNameHCIDCharge
ReactantHydrochloric AcidHCID 313—
ReactantPotassium HydroxideHCID 14797—
Reactant(2,2-Diethoxyethyl)dimethylamineHCID 77163—
ReactantLithium ChlorideHCID 433294—
ReactantHCID 86668939HCID 86668939—
SolventWaterHCID 962—
SolventTetrahydrofuranHCID 8028—
SolventDimethylacetamideHCID 31374—
SolventDichloromethane methanolHCID 21226129—
ProductKinase inhibitor-1HCID 5103765898.3%

Reaction Conditions

Temperature40 °C

Reaction Steps

To a stirred mixture of 2,2-diethoxy-N,N-dimethylethanamine (2.11 g, 13.1 mmol) and water (2.2 mL) at room temperature and under a nitrogen atmosphere was added an aq. 37% HCl (2.19 mL, 26.1 mmol). After addition the mixture was stirred at 40° C. (bath) for 21 h. It was cooled to 0° C. (bath). This is called solution A. KOH (1.87 g, 33.4 mmol) was dissolved in water (10 mL) at room temperature under a nitrogen atmosphere. It was cooled to 0° C. (bath). This is called solution B. To a stirred heterogeneous mixture of compound 232 (2.76 g, 5.22 mmol) and THF (10 mL) at room temperature and under a nitrogen atmosphere was added minimum amount of DMA (5.5 mL) to give a homogeneous solution. LiCl (221 mg, 5.22 mmol) was added and stirred at 0° C. (bath) for 15 min, The cold solution B was added and stirred at 0° C. for 2 min. Then the cold solution A was added and the final reaction mixture was continued to stir at 0° C. under a nitrogen atmosphere. The reaction was monitored by TLC (DCM-MeOH=10:1). After 35 min, it was poured into water (300 mL). Petroleum ether (300 mL) was added and stirred at room temperature for 15 min. Petroleum ether layer was decanted. More petroleum ether (300 mL) was added and stirred for 15 min. The solid was collected by suction filtration; washed with water (4×30 mL); dried under reduced pressure over silica gel/KOH to give (2E)-N-[4-(3-bromo-4-chloroanilino)pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)-2-butenamide (5) (2.37 g, 98%) as a pale yellow solid, mp 168-171; HPLC: 96.8% pure; 1H NMR δ [(CD3)2SO] 10.92 (s, 1H), 10.34 (s, 1H), 9.10-8.95 (m, 2H), 8.67 (br s, 1 H), 8.38 (br s, 1 H), 7.97 (br d, J=8.3 Hz, 1H), 7.65 (d, J=8.8, 1H), 6.88 (dt, J=15.4, 6.0 Hz, 1H), 6.52 (br d, J=15.4 Hz, 1H), 3.09 (dd, J=6.0, 1.1 Hz, 2H), 2.19 (s, 6H). Anal. Calcd for C19H18BrClN6O.H2O: C, 47.57; H, 4.20; N, 17.52. Found C, 47.80; H, 4.25; N, 17.51.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS09101632B2
Source datasetuspto-grants-2015_08
ORD IDord-6d660dcf6c1a495b9d2afdeb65b2104a
Source noteuspto-grants-2015_08